Larry Quinlan - 15 Sep 2025 Form 4 Insider Report for Booking Holdings Inc. (BKNG)

Role
Director
Signature
/s/ Vijay Iyer, Attorney-in-Fact
Issuer symbol
BKNG
Transactions as of
15 Sep 2025
Net transactions value
-$352,755
Form type
4
Filing time
16 Sep 2025, 16:30:17 UTC
Previous filing
09 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quinlan Larry Director BOOKING HOLDINGS INC., 800 CONNECTICUT AVE, NORWALK /s/ Vijay Iyer, Attorney-in-Fact 16 Sep 2025 0001876796

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BKNG Common Stock Sale $10,854 -2 -1% $5427.02 193 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,392 -3 -1.6% $5463.88 190 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,410 -3 -1.6% $5470.13 187 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $10,978 -2 -1.1% $5489.12 185 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,490 -1 -0.54% $5490.00 184 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $10,982 -2 -1.1% $5491.08 182 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $10,987 -2 -1.1% $5493.48 180 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $11,006 -2 -1.1% $5502.96 178 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,516 -3 -1.7% $5505.27 175 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $11,017 -2 -1.1% $5508.35 173 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,510 -1 -0.58% $5509.74 172 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,512 -1 -0.58% $5511.57 171 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,538 -3 -1.8% $5512.56 168 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,513 -1 -0.6% $5513.09 167 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,517 -1 -0.6% $5517.02 166 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,556 -3 -1.8% $5518.57 163 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,557 -3 -1.8% $5519.02 160 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,561 -3 -1.9% $5520.21 157 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,562 -3 -1.9% $5520.58 154 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $11,046 -2 -1.3% $5523.24 152 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $11,050 -2 -1.3% $5524.93 150 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,525 -1 -0.67% $5525.44 149 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $11,057 -2 -1.3% $5528.28 147 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,529 -1 -0.68% $5528.68 146 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,586 -3 -2.1% $5528.69 143 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,599 -3 -2.1% $5533.04 140 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $5,534 -1 -0.71% $5533.60 139 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $16,637 -3 -2.2% $5545.59 136 15 Sep 2025 By Revocable Trust F1
transaction BKNG Common Stock Sale $27,737 -5 -3.7% $5547.33 131 15 Sep 2025 By Revocable Trust F1
holding BKNG Common Stock 48 15 Sep 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The 10b5-1(c) sales plan was adopted on June 9, 2025.